Abrdn World Healthcare Fund (NYSE:THW – Get Free Report) saw a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling 139,544 shares, an increase of 206.3% from the February 26th total of 45,555 shares. Based on an average daily volume of 140,687 shares, the short-interest ratio is presently 1.0 days.
Hedge Funds Weigh In On Abrdn World Healthcare Fund
Several institutional investors and hedge funds have recently modified their holdings of the business. Mercer Global Advisors Inc. ADV bought a new position in Abrdn World Healthcare Fund during the fourth quarter worth about $157,000. Readystate Asset Management LP bought a new stake in Abrdn World Healthcare Fund in the 4th quarter valued at about $1,939,000. Kovack Advisors Inc. acquired a new position in shares of Abrdn World Healthcare Fund during the 4th quarter worth approximately $251,000. Osaic Holdings Inc. grew its position in shares of Abrdn World Healthcare Fund by 10.3% during the 4th quarter. Osaic Holdings Inc. now owns 129,764 shares of the company’s stock worth $1,658,000 after purchasing an additional 12,116 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in shares of Abrdn World Healthcare Fund by 0.9% during the fourth quarter. Royal Bank of Canada now owns 446,743 shares of the company’s stock worth $5,710,000 after purchasing an additional 4,138 shares during the period.
Abrdn World Healthcare Fund Stock Performance
THW traded down $0.43 during trading on Friday, hitting $11.36. The stock had a trading volume of 122,618 shares, compared to its average volume of 160,590. The company has a 50 day moving average price of $12.47 and a 200-day moving average price of $12.56. Abrdn World Healthcare Fund has a one year low of $9.80 and a one year high of $13.19.
Abrdn World Healthcare Fund Dividend Announcement
Abrdn World Healthcare Fund Company Profile
Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.
The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.
Read More
Receive News & Ratings for Abrdn World Healthcare Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn World Healthcare Fund and related companies with MarketBeat.com's FREE daily email newsletter.
